www.rmpd.org.uk

You are here: Home > Abstracts > Imaging > Sentinel node biopsy

Sentinel node biopsy

Background: The aim of this study was to determine the feasibility and accuracy of sentinel lymph node (SLN) biopsy for oesophageal adenocarcinoma.

Methods: Fifty-seven patients with adenocarcinoma of the lower oesophagus (n = 40) or gastric cardia (n = 17) underwent endoscopic peritumoral injection of (99m)Tc-radiolabelled nanocolloid before en bloc resection with extended lymphadenectomy. SLNs were identified during surgery using a handheld gamma probe and the pattern of radioactive uptake was quantified after operation. All 1667 resected lymph nodes were examined immunohistochemically for micrometastases.

Results: SLNs were identified in all 57 patients.They contained metastases (n = 32) or micrometastases (n = 3) in 35 of 37 node-positive patients and there were two false-negative studies. The overall accuracy of SLN biopsy was 96 per cent and SLNs were more likely to contain tumour than other lymph nodes (P < 0.001). Tumour-infiltrated nodal stations had a higher proportion of radioactive uptake (P < 0.001). Lower oesophageal tumours had a greater proportion of SLNs (P = 0.018), radioactive uptake (P < 0.001) and malignant nodes (P = 0.004) in the mediastinum than gastric cardia tumours.

Conclusion: The sentinel node concept is applicable to oesophageal adenocarcinoma and could be used to tailor the extent of lymphadenectomy. There is a close relationship between patterns of radioactive uptake and lymphatic tumour dissemination, which differ for lower oesophageal and gastric cardia tumours.

Publication

Lamb PJ, Griffin SM, Burt AD, Lloyd J, Karat D, Hayes N. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005 Jan;92(1):60-7.

Contact

Dr. Jim Lloyd, RVI Unit, Newcastle upon Tyne. Tel: +44 (0)191-233-6161.

Top of page

W3C XHTML 1.0 logo
W3C CSS logo
Triple-A conformance icon, W3C-WAI Web Content Accessibility Guidelines 1.0
Internet Content Rating Association logo

Regional Medical Physics Department, Newcastle General Hospital, Newcastle upon Tyne, NE4 6BE, UK.
Tel: +44 (0)191-233-6161 Fax: +44 (0)191-226-0970 E-mail: webmaster@rmpd.org.uk Web: http://www.rmpd.org.uk
By using this site you agree to our Terms and Conditions of Use. Please read our legal page.
Regional Medical Physics Department, a Clinical Directorate of the Newcastle upon Tyne Hospitals NHS Foundation Trust.
Copyright ©1999-2008 All Rights Reserved. Revised 28 April, 2008.

This Web Site

Accessibility | Feedback | Help | Links | Site Map | What's New |

Our Organisation

FAQs | Find Us | News & Events | Services | Work For Us |

Our Research

Abstracts | Innovation | Publications | What We Do |

Quick Site Search

Advanced search